NEW YORK (GenomeWeb News) – Link Technologies today announced a deal with American International Chemical for the distribution of some Link products in North America.

Under the terms of the deal, AIC will distribute a subset of the Bellshill, Scotland firm's oligonucleotide reagents. The deal focuses on the bulk market for oligonucleotide modifiers and will initially begin with the distribution of Link's modified phosphoramidites, including dyes and labels and CPG solid supports. The products will be distributed through AIC's Advanced Technology Division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.